7:04 pm Amgen: Phase 3 DECISION Trial of NEXAVAR (sorafenib) in thyroid cancer refractory to radioactive iodine published in The Lancet

more

View todays social media effects on AMGN

View the latest stocks trending across Twitter. Click to view dashboard

See who Amgen is hiring next, click here to view